Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction

Sponsor: Northumbria University

NCT ID: NCT07281755

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
Mix of remote tasks and in-person visits
Drug or intervention
Not specified by the sponsor
How long the study runs
Study runs about 25 months (dates as stated)
About the drug or intervention
Not specified by the sponsor
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
50 Years and over
Who
All
Number of participants
60
Started
2025-08-08
Last checked
2025-09

Plain English Summary

What is this study?

  • • Testing a new treatment for parkinson disease(pd)
  • • Clinical study - 60 participants
  • • The main objective of this observational trial is to explore the validity and reliability of DANU smart socks when used for mobility assessments in people with Parkinson's

Who can take part?

  • • Ages 50 Years and over
  • • Diagnosed with parkinson disease(pd)

Where?

  • • Newcastle upon Tyne - Northumbria University

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The main objective of this observational trial is to explore the validity and reliability of DANU smart socks when used for mobility assessments in people with Parkinson's. Using a series of laboratory gold standard equipment, this project aims to compare the metrics observed by DANU to the reference standards. No intervention is included. Specifically, this study will explore metrics relating to walking (gait) and balance of a Parkinson's cohort through a series of motor tasks. Moreover, this study seeks to investigate the clinical validity of DANU outcome metrics exploring relationships with clinical scales, fall history and prospective falls.

More detail

Background: Mobility impairments are common in Parkinson's disease (PD) and increase the risk of falling. Data derived from wearable inertial measurement units can provide useful information regarding gait in different situations and environments, which may help to identify those at risk of falling. However, rigorous testing is required to evaluate whether new devices are fit for purpose. DANU Smart Socks are a multi-modal system for movement analysis, containing 15 silicone based capacitive pressure sensors and an IMU pod, with tri-axal accelerometers, gyroscope and magnetometers, currently at use within a sporting context. Potential has been highlighted for clinical use in people with Parkinson's (PwP). This study aims to evaluate the validity, reliability and usability of the DANU Sport System in PwP for balance and gait assessment. The V3+ framework for determining fit-for-purpose biometric monitoring devices will be employed, evaluating verification, usability, analytical and clinical validation. Methods: Institutional ethics have been obtained (Project ID: 8543). Utilising a a repeated measures observational design, participants will be asked to attend two visits to Northumbria University, Newcastle Upon Tyne. Visit 1: Participants will complete a series of clinical and cognitive measures including the Movement Disorders Society's-Unified Parkinson's Disease Rating Scale, Montreal Cognitive Assessment, Freezing of Gait Questionnaire and Falls Efficacy Scale. Following this, concurrent data collection will occur throughout a battery of motor tasks to observe gait/balance metrics. Laboratory references employed include Axivity AX6, Vicon 3D Motion Capture, APDM Mobility Lab, GAITRite and AMTI Force Plates. Mobility assessments include a 2-Minute Walk Test, 3 walkway trials, a Timed Up and Go and a series of 2-Minute Balance tasks. Visit 2: Participants attend a second visit to repeat the mobility assessment previously detailed utilizing DANU Smart Socks and APDM Mobility Lab systems to explore test-retest reliability. Wearable device (DANU) validity and reliability will be examined using intra-class correlation coefficients and Bland-Altman plots to compare to laboratory reference standards. Moreover time series plots will be employed to evaluate the raw data agreement.

Parkinson Disease(PD)

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 50 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria.
  • ✓Hoehn \& Yahr stages I-III
  • ✓Able to attend Northumbria University, Newcastle Upon Tyne for study visits
  • ✓Able to walk and stand unassisted for a minimum of 2-minutes

Who cannot take part

  • ✗History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury,...
  • ✗Montreal Cognitive Assessment (MoCA) score \< 21
  • ✗Injury to the lower extremities within the past 6-weeks.
See the full criteria
Inclusion Criteria: * Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria. * Hoehn \& Yahr stages I-III * Able to attend Northumbria University, Newcastle Upon Tyne for study visits * Able to walk and stand unassisted for a minimum of 2-minutes Exclusion Criteria: * History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.) * Montreal Cognitive Assessment (MoCA) score \< 21 * Injury to the lower extremities within the past 6-weeks.

Where Is This Study? (1 UK site)

Northumbria University

Newcastle upon Tyne, United Kingdom

Recruiting
Site contact (verified)
Rodrigo Vitorio, PhDPrincipal Investigator

How to Get in Touch

Gabriella R Gatti, BSc

Sponsor contact

CONTACT

01912273343 gabriella.gatti@northumbria.ac.uk

Rodrigo Vitorio, PhD

Sponsor contact

CONTACT

01912273343 rodrigo.vitorio@northumbria.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2025-09